ANIK
Price
$9.01
Change
+$0.01 (+0.11%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
129.76M
34 days until earnings call
LIVN
Price
$53.44
Change
+$1.16 (+2.22%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
2.85B
33 days until earnings call
Interact to see
Advertisement

ANIK vs LIVN

Header iconANIK vs LIVN Comparison
Open Charts ANIK vs LIVNBanner chart's image
Anika Therapeutics
Price$9.01
Change+$0.01 (+0.11%)
Volume$1.2K
Capitalization129.76M
LivaNova
Price$53.44
Change+$1.16 (+2.22%)
Volume$17.87K
Capitalization2.85B
ANIK vs LIVN Comparison Chart in %
Loading...
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIK vs. LIVN commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIK is a Buy and LIVN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ANIK: $9.01 vs. LIVN: $53.44)
Brand notoriety: ANIK and LIVN are both not notable
ANIK represents the Pharmaceuticals: Generic, while LIVN is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ANIK: 17% vs. LIVN: 39%
Market capitalization -- ANIK: $129.76M vs. LIVN: $2.85B
ANIK [@Pharmaceuticals: Generic] is valued at $129.76M. LIVN’s [@Medical/Nursing Services] market capitalization is $2.85B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.85B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIK’s FA Score shows that 0 FA rating(s) are green whileLIVN’s FA Score has 0 green FA rating(s).

  • ANIK’s FA Score: 0 green, 5 red.
  • LIVN’s FA Score: 0 green, 5 red.
According to our system of comparison, LIVN is a better buy in the long-term than ANIK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIK’s TA Score shows that 3 TA indicator(s) are bullish while LIVN’s TA Score has 3 bullish TA indicator(s).

  • ANIK’s TA Score: 3 bullish, 3 bearish.
  • LIVN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ANIK is a better buy in the short-term than LIVN.

Price Growth

ANIK (@Pharmaceuticals: Generic) experienced а +1.24% price change this week, while LIVN (@Medical/Nursing Services) price change was -2.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.97%. For the same industry, the average monthly price growth was +24.39%, and the average quarterly price growth was +67.10%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was +3.18%, and the average quarterly price growth was +9.30%.

Reported Earning Dates

ANIK is expected to report earnings on Oct 30, 2025.

LIVN is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.97% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIVN($2.86B) has a higher market cap than ANIK($130M). LIVN YTD gains are higher at: 15.385 vs. ANIK (-45.322). ANIK has higher annual earnings (EBITDA): -2.24M vs. LIVN (-66.77M). LIVN has more cash in the bank: 594M vs. ANIK (53.2M). ANIK has less debt than LIVN: ANIK (25M) vs LIVN (483M). LIVN has higher revenues than ANIK: LIVN (1.31B) vs ANIK (115M).
ANIKLIVNANIK / LIVN
Capitalization130M2.86B5%
EBITDA-2.24M-66.77M3%
Gain YTD-45.32215.385-295%
P/E RatioN/A30.31-
Revenue115M1.31B9%
Total Cash53.2M594M9%
Total Debt25M483M5%
FUNDAMENTALS RATINGS
ANIK vs LIVN: Fundamental Ratings
ANIK
LIVN
OUTLOOK RATING
1..100
1058
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
8949
P/E GROWTH RATING
1..100
6999
SEASONALITY SCORE
1..100
2514

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LIVN's Valuation (71) in the Medical Specialties industry is in the same range as ANIK (92) in the Pharmaceuticals Other industry. This means that LIVN’s stock grew similarly to ANIK’s over the last 12 months.

LIVN's Profit vs Risk Rating (91) in the Medical Specialties industry is in the same range as ANIK (100) in the Pharmaceuticals Other industry. This means that LIVN’s stock grew similarly to ANIK’s over the last 12 months.

LIVN's SMR Rating (95) in the Medical Specialties industry is in the same range as ANIK (97) in the Pharmaceuticals Other industry. This means that LIVN’s stock grew similarly to ANIK’s over the last 12 months.

LIVN's Price Growth Rating (49) in the Medical Specialties industry is somewhat better than the same rating for ANIK (89) in the Pharmaceuticals Other industry. This means that LIVN’s stock grew somewhat faster than ANIK’s over the last 12 months.

ANIK's P/E Growth Rating (69) in the Pharmaceuticals Other industry is in the same range as LIVN (99) in the Medical Specialties industry. This means that ANIK’s stock grew similarly to LIVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIKLIVN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 9 days ago
64%
Bullish Trend 18 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BINIX33.06N/A
N/A
Baron International Growth Institutional
FFECX14.81N/A
N/A
Nuveen Dividend Value C
JSVDX15.89N/A
N/A
Janus Henderson Small-Mid Cap Value D
MRVSX27.67N/A
N/A
Victory Integrity Small-Cap Value R
GBLEX40.67N/A
N/A
American Funds Global Balanced F1

ANIK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIK has been loosely correlated with AVNS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIK jumps, then AVNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIK
1D Price
Change %
ANIK100%
-0.77%
AVNS - ANIK
37%
Loosely correlated
-4.55%
FLGT - ANIK
34%
Loosely correlated
-0.32%
ORGO - ANIK
33%
Poorly correlated
-4.49%
LIVN - ANIK
32%
Poorly correlated
-1.78%
INFU - ANIK
30%
Poorly correlated
-1.66%
More

LIVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with ENOV. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIVN
1D Price
Change %
LIVN100%
+2.21%
ENOV - LIVN
50%
Loosely correlated
-0.13%
CRL - LIVN
47%
Loosely correlated
+2.04%
NVST - LIVN
44%
Loosely correlated
+1.80%
IQV - LIVN
42%
Loosely correlated
+1.59%
A - LIVN
38%
Loosely correlated
+1.22%
More